创新药概念股盘初活跃，亚宝药业触及涨停

Group 1 - The core viewpoint of the article highlights the active performance of innovative drug concept stocks, with notable gains in specific companies [1] - Yabao Pharmaceutical (600351) reached the daily limit increase, indicating strong market interest and investor confidence [1] - Key technologies saw a rise of over 7%, reflecting positive sentiment in the sector [1] Group 2 - Chengdu Xian Dao, Watson Bio (300142), and Shanghai Kaibao (300039) also experienced upward movement, suggesting a broader trend in the innovative drug industry [1]